Genetic predisposition to breast cancer: Past, present, and future

被引:192
|
作者
Turnbull, Clare [1 ]
Rahman, Nazneen [1 ]
机构
[1] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England
基金
英国医学研究理事会;
关键词
BRCA*; allele; familial; susceptibility; penetrance;
D O I
10.1146/annurev.genom.9.081307.164339
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
In recent years, our understanding of genetic predisposition to breast cancer has advanced significantly. Three classes of predisposition factors, categorized by their associated risks of breast cancer, are currently known. BRCA1 and BRCA2 are high-penetrance breast cancer predisposition genes identified by genome-wide linkage analysis and positional cloning. Mutational screening of genes functionally related to BRCA1 and/or BRCA2 has revealed four genes, CHEK2, ATM, BRIP1, and PALB2; mutations in these genes are rare and confer an intermediate risk of breast cancer. Association studies have further identified eight common variants associated with low-penetrance breast cancer predisposition. Despite these discoveries, most of the familial risk of breast cancer remains unexplained. In this review, we describe the known genetic predisposition factors, expound on the methods by which they were identified, and consider how further technological and intellectual advances may assist in identifying the remaining genetic factors underlying breast cancer susceptibility.
引用
收藏
页码:321 / 345
页数:25
相关论文
共 50 条
  • [1] Common Genetic Variation and Breast Cancer Risk-Past, Present, and Future
    Lilyquist, Jenna
    Ruddy, Kathryn J.
    Vachon, Celine M.
    Couch, Fergus J.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (04) : 380 - 394
  • [2] Breast cancer genetics: the past, present and future
    Sivapalaratnam, S.
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 2014, 72 (01): : 3 - 4
  • [3] Immunotherapy for breast cancer: past, present, and future
    Alison Spellman
    Shou-Ching Tang
    [J]. Cancer and Metastasis Reviews, 2016, 35 : 525 - 546
  • [4] Breast cancer screening: past, present and future
    Jatoi, Ismail
    [J]. FUTURE ONCOLOGY, 2015, 11 (19) : 2621 - 2624
  • [5] Immunotherapy for breast cancer: past, present, and future
    Spellman, Alison
    Tang, Shou-Ching
    [J]. CANCER AND METASTASIS REVIEWS, 2016, 35 (04) : 525 - 546
  • [6] Breast cancer in Chile: past, present and future
    Serra C, Ivan
    [J]. REVISTA CHILENA DE CIRUGIA, 2011, 63 (06): : 553 - 556
  • [7] Discusses the Past, Present, and Future of Breast Cancer Research
    Kalinsky, Kevin
    [J]. ONCOLOGY-NEW YORK, 2023, 37 (01):
  • [8] Axillary surgery for breast cancer: past, present, and future
    Noguchi, Masakuni
    Inokuchi, Masafumi
    Noguchi, Miki
    Morioka, Emi
    Ohno, Yukako
    Kurita, Tomoko
    [J]. BREAST CANCER, 2021, 28 (01) : 9 - 15
  • [9] Hormonal intervention in breast cancer - Past, present, and future
    Osborne, MP
    [J]. BASIS FOR CANCER MANAGEMENT, 1996, 784 : 427 - 432
  • [10] The past, present and future of breast cancer research in China
    Hong, Wei
    Dong, Erdan
    [J]. CANCER LETTERS, 2014, 351 (01) : 1 - 5